NF-κB inhibitors impair platelet activation responses

Journal of Thrombosis and Haemostasis

Volumn 7, Issue 8, 2009, Pages 1333-1343

  Malaver, E ^a   Romaniuk, M A ^a   D'atri, L P ^a   Pozner, R G ^a   Negrotto, S ^a   Benzadon R ^b   Schattner, Mirta ^a  

^a Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

^b CEMIC   (Argentina)

Author keywords

IIb 3; cPLA2; NF B; Platelets; TXB2

Indexed keywords

3 (4 METHYLPHENYLSULFONYL) 2 PROPENENITRILE; 6 (PHENYLSULFINYL)TETRAZOLO[1,5 B]PYRIDAZINE; ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ADRENALIN; ANTIINFLAMMATORY AGENT; ARACHIDONIC ACID; COLLAGEN; CYTOSOLIC PHOSPHOLIPASE A2; FIBRINOGEN; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTEGRIN; INTEGRIN ALPHA2B BETA3; MITOGEN ACTIVATED PROTEIN KINASE; PADGEM PROTEIN; RO 1069920; THROMBIN; THROMBOXANE B2; TRANSCRIPTION FACTOR RELA; UNCLASSIFIED DRUG; DUAL SPECIFICITY PHOSPHATASE 2; DUSP2 PROTEIN, HUMAN; I KAPPA B; NF KAPPAB INHIBITOR ALPHA; NF-KAPPAB INHIBITOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLEEDING TIME; CONTROLLED STUDY; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; MALE; MOUSE; NONHUMAN; NORMAL HUMAN; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION INHIBITION; WESTERN BLOTTING; ANIMAL; CELL CULTURE; DRUG ANTAGONISM; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; THROMBOCYTE ADHESIVENESS;

ANIMALS; CELLS, CULTURED; DUAL SPECIFICITY PHOSPHATASE 2; FIBRINOGEN; HUMANS; I-KAPPA B PROTEINS; MICE; NF-KAPPA B; PHOSPHORYLATION; PLATELET ACTIVATION; PLATELET ADHESIVENESS; PROTEIN BINDING;

EID: 67949085160     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2009.03492.x     Document Type: Article

References (22)

1. Ghosh S, Hayden MS. New regulators of NF-kappaB in inflammation. Nat Rev Immunol 2008; 8: 837-48.
2. Khetawat G, Faraday N, Nealen ML, Vijayan KV, Bolton E, Noga SJ, Bray PF. Human megakaryocytes and platelets contain the estrogen receptor beta and androgen receptor (AR): Testosterone regulates AR expression. Blood 2000; 95: 2289-96.
3. Ali FY, Davidson SJ, Moraes LA, Traves SL, Paul-Clark M, Bishop-Bailey D, Warner TD, Mitchell JA. Role of nuclear receptor signaling in platelets: Antithrombotic effects of PPARbeta. FASEB J 2006; 20: 326-8.
4. Akbiyik F, Ray DM, Gettings KF, Blumberg N, Francis CW, Phipps RP. Human bone marrow megakaryocytes and platelets express PPARgamma, and PPARgamma agonists blunt platelet release of CD40 ligand and thromboxanes. Blood 2004; 104: 1361-8.
5. Moraes LA, Paul-Clark MJ, Rickman A, Flower RJ, Goulding NJ, Perretti M. Ligand-specific glucocorticoid receptor activation in human platelets. Blood 2005; 106: 4167-75.
6. Moraes LA, Swales KE, Wray JA, Damazo A, Gibbins JM, Warner TD, Bishop-Bailey D. Nongenomic signaling of the retinoid X receptor through binding and inhibiting Gq in human platelets. Blood 2007; 109: 3741-4.
7. Moro L, Reineri S, Piranda D, Pietrapiana D, Lova P, Bertoni A, Graziani A, Defilippi P, Canobbio I, Torti M, Sinigaglia F. Nongenomic effects of 17beta-estradiol in human platelets: Potentiation of thrombin-induced aggregation through estrogen receptor beta and Src kinase. Blood 2005; 105: 115-21.
8. Liu F, Morris S, Epps J, Carroll R. Demonstration of an activation regulated NF-kappaB/I-kappaBalpha complex in human platelets. Thromb Res 2002; 106: 199-203.
9. Pierce JW, Schoenleber R, Jesmok G, Best J, Moore SA, Collins T, Gerritsen ME. Novel inhibitors of cytokine-induced IkappaBalpha phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo. J Biol Chem 1997; 272: 21096-103.
10. Swinney DC, Xu YZ, Scarafia LE, Lee I, Mak AY, Gan QF, Ramesha CS, Mulkins MA, Dunn J, So OY, Biegel T, Dinh M, Volkel P, Barnett J, Dalrymple SA, Lee S, Huber M. A small molecule ubiquitination inhibitor blocks NF-kappa B-dependent cytokine expression in cells and rats. J Biol Chem 2002; 277: 23573-81.
11. Shattil SJ, Newman PJ. Integrins: Dynamic scaffolds for adhesion and signaling in platelets. Blood 2004; 104: 1606-15.
12. Sage SO. The Wellcome Prize Lecture. Calcium entry mechanisms in human platelets. Exp Physiol 1997; 82: 807-23.
13. Adam F, Kauskot A, Rosa JP, Bryckaert M. Mitogen-activated protein kinases in hemostasis and thrombosis. J Thromb Haemost 2008; 6: 2007-16.
14. Shankar H, Garcia A, Prabhakar J, Kim S, Kunapuli SP. P2Y12 receptor-mediated potentiation of thrombin-induced thromboxane A2 generation in platelets occurs through regulation of Erk1/2 activation. J Thromb Haemost 2006; 4: 638-47.
15. Leslie CC. Properties and regulation of cytosolic phospholipase A2. J Biol Chem 1997; 272: 16709-12.
16. Borsch-Haubold AG, Kramer RM, Watson SP. Phosphorylation and activation of cytosolic phospholipase A2 by 38-kDa mitogen-activated protein kinase in collagen-stimulated human platelets. Eur J Biochem 1997; 245: 751-9.
17. Adler DH, Cogan JD, Phillips JA 3rd, Schnetz-Boutaud N, Milne GL, Iverson T, Stein JA, Brenner DA, Morrow JD, Boutaud O, Oates JA. Inherited human cPLA(2alpha) deficiency is associated with impaired eicosanoid biosynthesis, small intestinal ulceration, and platelet dysfunction. J Clin Invest 2008; 118: 2121-31.
18. Prevost N, Mitsios JV, Kato H, Burke JE, Dennis EA, Shimizu T, Shattil SJ. Group IVA cytosolic phospholipase A2 (cPLA2alpha) and integrin alphaIIbbeta3 reinforce each other's functions during alphaIIbbeta3 signaling in platelets. Blood 2009; 113: 447-57.
19. Salanova B, Choi M, Rolle S, Wellner M, Luft FC, Kettritz R. Beta2-integrins and acquired glycoprotein IIb/IIIa (GPIIb/IIIa) receptors cooperate in NF-kappaB activation of human neutrophils. J Biol Chem 2007; 282: 27960-9.
20. Zarbock A, Polanowska-Grabowska RK, Ley K. Platelet-neutrophil-interactions: Linking hemostasis and inflammation. Blood Rev 2007; 21: 99-111.
21. Egashira K, Suzuki J, Ito H, Aoki M, Isobe M, Morishita R. Long-term follow up of initial clinical cases with NF-kappaB decoy oligodeoxynucleotide transfection at the site of coronary stenting. J Gene Med 2008; 10: 805-9.
22. Li XC, Zhuo JL. Nuclear factor-kappaB as a hormonal intracellular signaling molecule: Focus on angiotensin II-induced cardiovascular and renal injury. Curr Opin Nephrol Hypertens 2008; 17: 37-43.